Unilateral cutaneous ureterostomy with separate stomata vs ileal conduit after radical cystectomy

Table 1 Demographic and clinical characteristics of all patients, median (range)/n (%)

Variables	Value
Age (years)	61 (48-83)
BMI (kg/m2)	23.95 (19.2-30.2)
eGFR (mL/minute)	97.5 (16-117)
Hemoglobin (g/dL)	12.25 (9-16.3)
Serum creatinine (mg/dL)	0.9 (0.5-3.9)
Smoking	23 (71.9)
Medical comorbidities	12 (37.5)
Tumor stage
T1	8 (25)
T2	17 (53.1)
T3	7 (21.9)
Tumor histopathology
TCC	19 (59.4)
Squamous cell carcinoma	3 (9.4)
Adenocarcinoma	1 (3.1)
TCC with variants	9 (28.1)
Neoadjuvant therapy
Chemotherapy	7 (21.9)
Radiotherapy	2 (6.3)
Intravesical BCG	4 (12.5)
Comorbidities
Diabetes	7 (21.9)
Hypertension	5 (15.6)
Cardiac	1 (3.1)
COPD	2 (6.3)
Operative characteristics
Operative time (minutes)	357.5 (250-500)
Operative time for shunt (minutes)	100 (40-165)
Blood loss (cc)	925 (600-2000)
Blood transfusion (Units per patient)	2 (1-4)
Postoperative day-1 hemoglobin level (g/dL)	10.6 (7.7-13.6)
Postoperative day-1 serum creatinine level (mg/dL)	1.1 (0.6-3.3)
Number of retrieved lymph nodes	18 (4-39)
Incidence of perioperative complications	31 (96.95)
Complication grade
Low or no complications	25 (78.1)
High	7 (21.9)
Hospital stay (days)	12 (3-55)
Follow-up
Duration (months)	10 (6-24)
Serum creatinine (mg/dL)	1.1 (0.8-4.1)
eGFR (ml/minute)	74 (14-101)
Days between appliance base changes1	10 (5-25)
QoL score	71 (52-103)
Febrile UTI	9 (36)

¹The higher the number of days between changes of the appliance base, the lower the frequency of changes. This was an advantageous finding because it meant that the appliance is durable and long-lasting with lower costs.

BMI: Body mass index; eGFR: Estimated glomerular filtration rate; TCC: Transitional cell carcinoma; BCG: Bacillus-Calmette-Geurin; COPD: Chronic obstructive pulmonary disease; QoL: Quality-of-life; UTI: Urinary tract infection.